Real-time enrollment status for this b acute lymphoblastic leukemia, philadelphia chromosome negative clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:38 PM UTC
| NCT Number | NCT03739814 |
| Recruiting Status | Recruiting |
| Condition | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
| Phase | PHASE2 |
| Target Enrollment | 84 participants |
| Active Locations | 279 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 7, 2026 (5 days ago) |
As of October 12, 2026: Clinical trial NCT03739814 is currently recruiting participants. This phase2 study for b acute lymphoblastic leukemia, philadelphia chromosome negative is actively seeking new participants at 279 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03739814 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 279 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03739814 was last updated 5 days ago (October 7, 2026). HelloStudys verifies this status automatically.